共 50 条
- [2] Effects of an Out-of-Pocket Maximum in Medicare Part D [J]. AMERICAN JOURNAL OF MANAGED CARE, 2022, 28 (02): : E55 - +
- [10] Out-of-Pocket Costs for Infliximab and Its Biosimilar for Rheumatoid Arthritis Under Medicare Part D [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2018, 320 (09): : 931 - 933